Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 6 Imaging methods used to study Parkinson disease

Published byKarin Gunnarsson Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 6 Imaging methods used to study Parkinson disease"— Presentation transcript:

1 Figure 6 Imaging methods used to study Parkinson disease
Part c is adapted with permission from Reiter, E. et al. Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism. Mov Disord. 30, 1068–1076 (2015), Wiley. Part d is adapted with permission from Ohtsuka, C. et al. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson’s disease using neuromelanin-sensitive MR imaging. Neurosci. Lett. 541, 93–98 (2013), Elsevier. Part e is adapted with permission from Schmidauer, C. et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann. Neurol. 58, 630–634 (2005), Wiley Poewe, W. et al. (2017) Parkinson disease Nat. Rev. Dis. Primers doi: /nrdp

Download ppt "Figure 6 Imaging methods used to study Parkinson disease"

Similar presentations

Figure 1 Venomous snakes

Figure 1 Venomous snakes
Fig. 4. Intraoperative microscope photograph (A) illustrating the location of the cavernoma in the left hemimedulla. Preoperative axial (B) and sagittal.

Fig. 4. Intraoperative microscope photograph (A) illustrating the location of the cavernoma in the left hemimedulla. Preoperative axial (B) and sagittal.
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 1 Incidence and mortality of cutaneous melanoma

Figure 1 Incidence and mortality of cutaneous melanoma
Figure 1 Perivenous distribution of multiple sclerosis lesions

Figure 1 Perivenous distribution of multiple sclerosis lesions
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 1 Anatomy of the spinal column

Figure 1 Anatomy of the spinal column
Figure 4 Time course of the development of physiological changes

Figure 4 Time course of the development of physiological changes
Figure 4 Cerebrospinal fluid levels of neurofilament light chain

Figure 4 Cerebrospinal fluid levels of neurofilament light chain
Figure 2 Overview of risk factors for Parkinson disease dementia

Figure 2 Overview of risk factors for Parkinson disease dementia
Reproduced with permission from Yancy, C. W. et al. 2017

Reproduced with permission from Yancy, C. W. et al. 2017
Figure 5 BMI and cardiorespiratory fitness levels

Figure 5 BMI and cardiorespiratory fitness levels
Figure 8 Implanted devices for the management of heart failure

Figure 8 Implanted devices for the management of heart failure
Figure 4 BMI and mortality in patients with heart failure

Figure 4 BMI and mortality in patients with heart failure
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Three-year survival rates on the basis of body composition

Figure 2 Three-year survival rates on the basis of body composition
Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast.

Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast.
Figure 7 European Society of Cardiology 2016

Figure 7 European Society of Cardiology 2016
Figure 4 Neuromyelitis optica spectrum disorder brain lesions

Figure 4 Neuromyelitis optica spectrum disorder brain lesions
Figure 3 Prediction of superconductivity in FeB4

Figure 3 Prediction of superconductivity in FeB4

Similar presentations

Ads by Google